Literature DB >> 10595544

Production of soluble alphabeta T-cell receptor heterodimers suitable for biophysical analysis of ligand binding.

B E Willcox1, G F Gao, J R Wyer, C A O'Callaghan, J M Boulter, E Y Jones, P A van der Merwe, J I Bell, B K Jakobsen.   

Abstract

A method to produce alphabeta T-cell receptors (TCRs) in a soluble form suitable for biophysical analysis was devised involving in vitro refolding of a TCR fusion protein. Polypeptides corresponding to the variable and constant domains of each chain of a human and a murine receptor, fused to a coiled coil heterodimerization motif from either c-Jun (alpha) or v-Fos (beta), were overexpressed separately in Escherichia coli. Following recovery from inclusion bodies, the two chains of each receptor were denatured, and then refolded together in the presence of denaturants. For the human receptor, which is specific for the immunodominant influenza A HLA-A2-restricted matrix epitope (M58-66), a heterodimeric protein was purified in milligram yields and found to be homogeneous, monomeric, antibody-reactive, and stable at concentrations lower than 1 microM. Using similar procedures, analogous results were obtained with a murine receptor specific for an influenza nucleoprotein epitope (366-374) restricted by H2-Db. Production of these receptors has facilitated a detailed analysis of viral peptide-Major Histocompatibility Complex (peptide-MHC) engagement by the TCR using both surface plasmon resonance (SPR) and, in the case of the human TCR, isothermal titration calorimetry (ITC) (Willcox et al., 1999). The recombinant methods described should enable a wide range of TCR-peptide-MHC interactions to be studied and may also have implications for the production of other heterodimeric receptor molecules.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10595544      PMCID: PMC2144200          DOI: 10.1110/ps.8.11.2418

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  22 in total

1.  Kinetic discrimination in T-cell activation.

Authors:  J D Rabinowitz; C Beeson; D S Lyons; M M Davis; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

2.  The T cell receptor from an influenza-A specific murine CTL clone.

Authors:  M S Palmer; A Bentley; K Gould; A R Townsend
Journal:  Nucleic Acids Res       Date:  1989-03-25       Impact factor: 16.971

Review 3.  The three-dimensional structure of peptide-MHC complexes.

Authors:  D R Madden
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

4.  Kinetic proofreading in T-cell receptor signal transduction.

Authors:  T W McKeithan
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

5.  Kinetics of T-cell receptor binding to peptide/I-Ek complexes: correlation of the dissociation rate with T-cell responsiveness.

Authors:  K Matsui; J J Boniface; P Steffner; P A Reay; M M Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

6.  A general method for facilitating heterodimeric pairing between two proteins: application to expression of alpha and beta T-cell receptor extracellular segments.

Authors:  H C Chang; Z Bao; Y Yao; A G Tse; E C Goyarts; M Madsen; E Kawasaki; P P Brauer; J C Sacchettini; S G Nathenson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

7.  Vectors for selective expression of cloned DNAs by T7 RNA polymerase.

Authors:  A H Rosenberg; B N Lade; D S Chui; S W Lin; J J Dunn; F W Studier
Journal:  Gene       Date:  1987       Impact factor: 3.688

8.  HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides.

Authors:  D N Garboczi; D T Hung; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

9.  Crystal structure of the heterodimeric bZIP transcription factor c-Fos-c-Jun bound to DNA.

Authors:  J N Glover; S C Harrison
Journal:  Nature       Date:  1995-01-19       Impact factor: 49.962

10.  Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment.

Authors:  P J Lehner; E C Wang; P A Moss; S Williams; K Platt; S M Friedman; J I Bell; L K Borysiewicz
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

View more
  24 in total

1.  Structural and energetic evidence for highly peptide-specific tumor antigen targeting via allo-MHC restriction.

Authors:  Amy A Simpson; Fiyaz Mohammed; Mahboob Salim; Amy Tranter; Alan B Rickinson; Hans J Stauss; Paul A H Moss; Neil M Steven; Benjamin E Willcox
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

Review 2.  Stable, soluble, high-affinity, engineered T cell receptors: novel antibody-like proteins for specific targeting of peptide antigens.

Authors:  J M Boulter; B K Jakobsen
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

3.  Crystallization and preliminary X-ray crystallographic characterization of a public CMV-specific TCR in complex with its cognate antigen.

Authors:  Jean Baptiste Reiser; François Legoux; Paul Machillot; Emilie Debeaupuis; Béatrice Le Moullac-Vaydie; Anne Chouquet; Xavier Saulquin; Marc Bonneville; Dominique Housset
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-10-30

4.  Crystal structure of leukocyte Ig-like receptor LILRB4 (ILT3/LIR-5/CD85k): a myeloid inhibitory receptor involved in immune tolerance.

Authors:  Hao Cheng; Fiyaz Mohammed; Gol Nam; Yong Chen; Jianxun Qi; Lee I Garner; Rachel L Allen; Jinghua Yan; Benjamin E Willcox; George F Gao
Journal:  J Biol Chem       Date:  2011-03-30       Impact factor: 5.157

5.  High affinity soluble ILT2 receptor: a potent inhibitor of CD8(+) T cell activation.

Authors:  Ruth K Moysey; Yi Li; Samantha J Paston; Emma E Baston; Malkit S Sami; Brian J Cameron; Jessie Gavarret; Penio Todorov; Annelise Vuidepot; Steven M Dunn; Nicholas J Pumphrey; Katherine J Adams; Fang Yuan; Rebecca E Dennis; Deborah H Sutton; Andy D Johnson; Joanna E Brewer; Rebecca Ashfield; Nikolai M Lissin; Bent K Jakobsen
Journal:  Protein Cell       Date:  2011-01-08       Impact factor: 14.870

6.  Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances affinity for cognate peptide-MHC without increasing apparent cross-reactivity.

Authors:  Steven M Dunn; Pierre J Rizkallah; Emma Baston; Tara Mahon; Brian Cameron; Ruth Moysey; Feng Gao; Malkit Sami; Jonathan Boulter; Yi Li; Bent K Jakobsen
Journal:  Protein Sci       Date:  2006-04       Impact factor: 6.725

7.  Facilitating matched pairing and expression of TCR chains introduced into human T cells.

Authors:  Jürgen Kuball; Michelle L Dossett; Matthias Wolfl; William Y Ho; Ralf-Holger Voss; Carla Fowler; Philip D Greenberg
Journal:  Blood       Date:  2006-11-02       Impact factor: 22.113

8.  Study on nanocomposite construction based on the multi-functional biotemplate self-assembled by the recombinant TMGMV coat protein for potential biomedical applications.

Authors:  Lei Song; Shiwen Wang; Haina Wang; Hua Zhang; Haolong Cong; Xingyu Jiang; Po Tien
Journal:  J Mater Sci Mater Med       Date:  2015-02-05       Impact factor: 3.896

9.  Secondary anchor polymorphism in the HA-1 minor histocompatibility antigen critically affects MHC stability and TCR recognition.

Authors:  Sarah Nicholls; Karen P Piper; Fiyaz Mohammed; Timothy R Dafforn; Stefan Tenzer; Mahboob Salim; Premini Mahendra; Charles Craddock; Peter van Endert; Hansjörg Schild; Mark Cobbold; Victor H Engelhard; Paul A H Moss; Benjamin E Willcox
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-20       Impact factor: 11.205

10.  Periplasmic expression of soluble single chain T cell receptors is rescued by the chaperone FkpA.

Authors:  Kristin S Gunnarsen; Elin Lunde; Per E Kristiansen; Bjarne Bogen; Inger Sandlie; Geir Å Løset
Journal:  BMC Biotechnol       Date:  2010-02-03       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.